Background: Soluble urokinase-type plasminogen activator receptor (suPAR) is a circulating protein that has been found as a promising biomarker for a variety of kidney injuries. The predictive utility of suPAR in contrast-induced acute kidney damage (CI-AKI) in percutaneous coronary intervention (PCI) is uncertain.
Aim: This study aimed to assess prediction CI-AKI using suPAR in patients undergoing PCI.
Methods: This case-control study was carried out on 80 subjects undergoing PCI. Subjects were divided into 2 groups 40 patients developed CI-AKI in addition to control group includes 40 subjects with non-CI-AKI. The radial or right femoral artery was punctured using the PCI Seldinger puncture technique. Specific laboratory investigation was evaluation of suPAR in serum using Luminex assay.
Results: The suPAR marker was a significant predictor of CI-AKI among PCI patients (AUC=0.982, P<0.001). suPAR cut off point (>2.55 ng/mL) showed sensitivity of 92.5%, specificity of 97.5% for the diagnosis of CI-AKI. Combined creatinine before contrast and suPAR cut off point showed sensitivity of 95%, specificity of 100%In CI-AKI patients, there was a significant positive correlation between suPAR marker levels and each of creatinine level after contrast (r=0.375, P=0.017) and urinary albumin creatinine ratio (r=0.396, P=0.011). Increased levels of suPAR were associated with higher odds (2334.63) of having CI-AKI.
Conclusion: Higher suPAR levels were detected in cases in comparison to controls. SuPAR showed accepted performance criteria in CI-AKI prediction. The combined creatinine level before contrast and suPAR improves the sensitivity and specificity. The suPAR is an independent predictor of CI-AKI in primary PCI.
Ahmed, A., Gab~Allah, A., Abdullah Mohamed, H., Elkot, M., & Esawy, M. (2024). Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Contrast-Induced Acute Kidney Injury in Percutaneous Coronary Intervention Patients. Zagazig University Medical Journal, 30(7), 3423-3432. doi: 10.21608/zumj.2024.281313.3314
MLA
Azza Moustafa Ahmed; Ahmed Mohamed Gab~Allah; Hend Sami Abdullah Mohamed; Moataz A. Elkot; Marwa Mohammed Esawy. "Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Contrast-Induced Acute Kidney Injury in Percutaneous Coronary Intervention Patients", Zagazig University Medical Journal, 30, 7, 2024, 3423-3432. doi: 10.21608/zumj.2024.281313.3314
HARVARD
Ahmed, A., Gab~Allah, A., Abdullah Mohamed, H., Elkot, M., Esawy, M. (2024). 'Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Contrast-Induced Acute Kidney Injury in Percutaneous Coronary Intervention Patients', Zagazig University Medical Journal, 30(7), pp. 3423-3432. doi: 10.21608/zumj.2024.281313.3314
VANCOUVER
Ahmed, A., Gab~Allah, A., Abdullah Mohamed, H., Elkot, M., Esawy, M. Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Contrast-Induced Acute Kidney Injury in Percutaneous Coronary Intervention Patients. Zagazig University Medical Journal, 2024; 30(7): 3423-3432. doi: 10.21608/zumj.2024.281313.3314